Corona Remedies shares make strong start, list at 38% premium over IPO priceCorona Remedies Share Price: Corona Remedies debuted on Dalal Street with a significant 38.42% premium, opening at Rs 1,470 on NSE and Rs 1...
15 Dec, 2025, 10.21 AM IST
Wakefit Innovations shares list flat at IPO price of Rs 195 on exchangesWakefit Innovations listed flat on Monday, debuting at Rs 195 on the NSE and slightly lower on the BSE, in line with muted grey market expe...
15 Dec, 2025, 10.07 AM IST
Corona Remedies and Wakefit Innovations to list tomorrow; GMP suggests sharp upside for pharma playCorona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expecta...
14 Dec, 2025, 11.01 AM IST
IPO Calendar next week: 4 new issues, ICICI Prudential AMC among 15 listings on investors radarIndia's primary market is buzzing with activity as four new public issues, totaling Rs 830 crore, are set to launch, led by KSH Internation...
13 Dec, 2025, 01.08 PM IST
How to check Corona Remedies IPO allotment on Bigshare Services as GMP stays strongCorona Remedies’ Rs 655-crore offer-for-sale IPO saw strong demand across investor categories, with overall subscription at 144.54 times an...
11 Dec, 2025, 11.35 AM IST
Wakefit Subscribed 2.52 times, Corona IPO 137 times on last dayWakefit Innovations' IPO saw a subscription of 2.52 times, with strong interest from retail and qualified institutional investors. Meanwhil...
11 Dec, 2025, 05.51 AM IST
Corona Remedies IPO Day 3: Issue subscribed over 18.5x, GMP at 25%. Should you apply?Corona Remedies' Rs 655.37-crore IPO is in its final subscription day. Investors show strong interest, with the issue subscribed 18.54 time...
10 Dec, 2025, 03.10 PM IST
Corona Remedies IPO Day 2: Nearly 3x subscription so far; check GMP trends & should you apply?Corona Remedies’ Rs 655-crore IPO entered Day 2 after achieving 62% subscription on Day 1, driven largely by retail demand. The IPO’s grey ...
09 Dec, 2025, 12.46 PM IST
Corona Remedies IPO Day 1: Registers over 30% subscription, strong GMP, and key detailsCorona Remedies’ IPO opened with decent subscription demand, led by strong retail demand and a robust Rs 290 grey-market premium. The Rs 65...
08 Dec, 2025, 02.35 PM IST
Corona Remedies IPO: Check GMP, price band, review, subscription and other detailsCorona Remedies' IPO is now open for subscription. The company is offering shares at a price band of Rs 1,008 to Rs 1,062. The issue aims t...
08 Dec, 2025, 09.52 AM IST
Is Corona Remedies’ IPO a compelling bet for long-term wealth creation?Corona Remedies is set to raise ₹655.4 crore via an offer for sale. The company focuses on specialist doctors, driving faster revenue growt...
08 Dec, 2025, 06.01 AM IST
IPO Calendar: ICICI Pru AMC, Wakefit to anchor Rs 13,000 crore pipeline next weekIndia’s primary market enters its busiest phase with 11 IPOs worth Rs 13,807 crore opening between December 8–17. Key issues include Corona...
06 Dec, 2025, 02.36 PM IST
Corona Remedies IPO opens next week: GMP among 10 things to know before subscriptionCorona Remedies is launching its Rs 655 crore IPO next week. The Gujarat-based pharmaceutical firm is offering 100% of its shares. The grey...
04 Dec, 2025, 11.30 AM IST
Pharma firm Corona Remedies IPO to open on Dec 8; sets price band at Rs 1,008-1,062/ sharePharma firm Corona Remedies, backed by ChrysCapital, has set its IPO price band at Rs 1,008-1,062, valuing the company at nearly Rs 6,500 c...
04 Dec, 2025, 10.43 AM IST
13 companies receive Sebi nod for IPOs including Urban Company, BoatSEBI has given the green light to 13 companies, including Urban Company and Boat's parent company, Imagine Marketing, to proceed with their...
03 Sep, 2025, 05.52 AM IST
From boAt to Urban Company: Sebi approves 13 IPOs in a week as markets brace for listing delugeSebi has cleared 13 IPOs in a week, including Urban Company’s ₹1,900 crore issue. The IPO will raise ₹429 crore via fresh shares and ₹1,471...
02 Sep, 2025, 01.40 PM IST
Corona Remedies files draft papers with Sebi for Rs 800 crore IPOCorona Remedies, an Indian pharmaceutical company, has filed preliminary documents with SEBI to launch an Rs 800-crore IPO. The IPO consist...
30 Apr, 2025, 09.56 PM IST